Cellectis Pink Sheet Forecast - Simple Exponential Smoothing
| CMVLF Stock | USD 4.40 0.00 0.00% |
Cellectis Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Cellectis' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 28th of January 2026 the relative strength index (rsi) of Cellectis' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Cellectis hype-based prediction, you can estimate the value of Cellectis SA from the perspective of Cellectis response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Cellectis SA on the next trading day is expected to be 4.40 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.64. Cellectis after-hype prediction price | USD 4.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cellectis |
Cellectis Additional Predictive Modules
Most predictive techniques to examine Cellectis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cellectis using various technical indicators. When you analyze Cellectis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cellectis Simple Exponential Smoothing Price Forecast For the 29th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Cellectis SA on the next trading day is expected to be 4.40 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.01, and the sum of the absolute errors of 0.64.Please note that although there have been many attempts to predict Cellectis Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cellectis' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cellectis Pink Sheet Forecast Pattern
| Backtest Cellectis | Cellectis Price Prediction | Buy or Sell Advice |
Cellectis Forecasted Value
In the context of forecasting Cellectis' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cellectis' downside and upside margins for the forecasting period are 2.99 and 5.81, respectively. We have considered Cellectis' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Cellectis pink sheet data series using in forecasting. Note that when a statistical model is used to represent Cellectis pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.9796 |
| Bias | Arithmetic mean of the errors | 0.0107 |
| MAD | Mean absolute deviation | 0.0107 |
| MAPE | Mean absolute percentage error | 0.0024 |
| SAE | Sum of the absolute errors | 0.64 |
Predictive Modules for Cellectis
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cellectis SA. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cellectis After-Hype Price Density Analysis
As far as predicting the price of Cellectis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cellectis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Cellectis, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cellectis Estimiated After-Hype Price Volatility
In the context of predicting Cellectis' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cellectis' historical news coverage. Cellectis' after-hype downside and upside margins for the prediction period are 2.99 and 5.81, respectively. We have considered Cellectis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cellectis is somewhat reliable at this time. Analysis and calculation of next after-hype price of Cellectis SA is based on 3 months time horizon.
Cellectis Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cellectis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cellectis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cellectis, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 1.41 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.40 | 4.40 | 0.00 |
|
Cellectis Hype Timeline
Cellectis SA is currently traded for 4.40. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cellectis is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.22%. %. The volatility of related hype on Cellectis is about 0.0%, with the expected price after the next announcement by competition of 4.40. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellectis SA recorded a loss per share of 2.95. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next expected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Cellectis to cross-verify your projections.Cellectis Related Hype Analysis
Having access to credible news sources related to Cellectis' direct competition is more important than ever and may enhance your ability to predict Cellectis' future price movements. Getting to know how Cellectis' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cellectis may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRRUF | Immutep Limited | 0.00 | 0 per month | 0.00 | 0.08 | 4.00 | 0.00 | 60.76 | |
| TRGNF | Transgene SA | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 61.69 | |
| FGHQF | Frontage Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CYDY | Cytodyn | 0.00 | 0 per month | 2.80 | 0 | 8.00 | (5.71) | 24.19 | |
| HNSBF | Hansa Biopharma AB | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 36.46 | |
| SLNCF | Silence Therapeutics plc | 0.00 | 0 per month | 0.00 | 0.01 | 11.11 | 0.00 | 58.78 | |
| NWBO | Northwest Biotherapeutics | 0.00 | 0 per month | 3.47 | 0.09 | 8.33 | (8.00) | 38.34 | |
| PBBIF | Probi AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CLVLF | Clinuvel Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.13 | 1.75 | 0.00 | 14.74 | |
| HLOSF | Healios KK | 0.00 | 0 per month | 0.00 | (0.18) | 0.00 | (6.34) | 30.18 |
Other Forecasting Options for Cellectis
For every potential investor in Cellectis, whether a beginner or expert, Cellectis' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cellectis Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cellectis. Basic forecasting techniques help filter out the noise by identifying Cellectis' price trends.Cellectis Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cellectis pink sheet to make a market-neutral strategy. Peer analysis of Cellectis could also be used in its relative valuation, which is a method of valuing Cellectis by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cellectis Market Strength Events
Market strength indicators help investors to evaluate how Cellectis pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cellectis shares will generate the highest return on investment. By undertsting and applying Cellectis pink sheet market strength indicators, traders can identify Cellectis SA entry and exit signals to maximize returns.
Cellectis Risk Indicators
The analysis of Cellectis' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cellectis' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cellectis pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.3801 | |||
| Standard Deviation | 1.34 | |||
| Variance | 1.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cellectis
The number of cover stories for Cellectis depends on current market conditions and Cellectis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cellectis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cellectis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Information and Resources on Investing in Cellectis Pink Sheet
When determining whether Cellectis SA is a strong investment it is important to analyze Cellectis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cellectis' future performance. For an informed investment choice regarding Cellectis Pink Sheet, refer to the following important reports:Check out Historical Fundamental Analysis of Cellectis to cross-verify your projections. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.